Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Annals of Thoracic Surgery

• Publication date

  1994-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0003-4975(94)90090-6PMID 8010779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma

  1993cited by this paper
• Gene therapy: adenovirus vectors.

  1993cited by this paper
• Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses

  1993cited by this paper
• Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA.

  1993cited by this paper
• The basic science of gene therapy.

  1993cited by this paper
• Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.

  1993cited by this paper
• In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

  1993cited by this paper
• Multiple transduction as a means of preserving ganciclovir chemosensitivity in sarcoma cells carrying retrovirally transduced herpes thymidine kinase genes.

  1992cited by this paper
• The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

  1991cited by this paper
• Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.

  1991cited by this paper
• Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.

  1990cited by this paper
• The epidemiology and pathogenesis of malignant mesothelioma.

  1989cited by this paper
• Interactions of cancer cells with the microvasculature during metastasis 1 2

  1988cited by this paper
• Development of adenovirus vectors for the expression of heterologous genes.

  1988cited by this paper
• Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.

  1987cited by this paper
• Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.

  1971cited by this paper

• Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling

  2024cites this paper
• Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis

  2023cites this paper
• The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma

  2022cites this paper
• Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response

  2022cites this paper
• Biological basis for novel mesothelioma therapies

  2021cites this paper
• BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state

  2018cites this paper
• A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.

  2018cites this paper
• HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma

  2017cites this paper
• Oncolytic Viral Therapy for Mesothelioma

  2017cites this paper
• SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma

  2017cites this paper
• Genetic Modification of the Lung Directed Toward Treatment of Human Disease

  2017cites this paper
• Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma

  2016influential citation
• KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma

  2016cites this paper
• HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

  2016cites this paper
• Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines

  2016cites this paper
• Chronic Inflammation in Malignant Mesothelioma Pathogenesis: Focus on HMGB1 Isoforms and Germline BAP1 Mutations

  2015cites this paper
• Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients

  2015influential citation
• Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models

  2015influential citation
• CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome

  2014influential citation
• Altered Protease–Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the β-Catenin Gene

  2014cites this paper
• Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5

  2014cites this paper
• PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1

  2013cites this paper
• Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)

  2013cites this paper
• Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo

  2013cites this paper
• ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma

  2013cites this paper
• BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma

  2013cites this paper
• Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.

  2013cites this paper
• A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Anti‐Tubulin Agents

  2013cites this paper
• Intracavitary therapeutics for pleural malignancies.

  2013cites this paper
• Correction: BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma

  2013cites this paper
• Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression

  2012cites this paper
• Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies

  2012cites this paper
• Cancer Therapy : Preclinical CSPG 4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

  2012cites this paper
• Novel Intrapleural Therapies for Malignant Diseases

  2012cites this paper
• Sensitivity of Global Translation to mTOR Inhibition in REN Cells Depends on the Equilibrium between eIF4E and 4E-BP1

  2011cites this paper
• Animal Models of Mesothelioma

  2011cites this paper
• What's the place of immunotherapy in malignant mesothelioma treatments?

  2010cites this paper
• Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib

  2010cites this paper
• MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.

  2010cites this paper
• Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

  2009cites this paper
• Gene therapy in pleural diseases

  2008cites this paper
• Intrapleural Therapy: from BCG to Therapeutic Genes

  2008cites this paper
• Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

  2007cites this paper
• Bortezomib Inhibits Nuclear Factor- K B ^ Dependent Survival and Has Potent In vivo Activity in Mesothelioma Preclinical

  2007cites this paper
• Single-Dose Intrapleural IFN-B GeneTransfer forMalignant PleuralMesotheliomaandMetastatic Pleural Effusions : HighRate ofAntitumor ImmuneResponses

  2007cites this paper
• [Immunotherapy and malignant mesothelioma: clinical perspectives].

  2007cites this paper
• A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses

  2007cites this paper
• Products are Selectively Expressed in Malignant Mesothelioma

  2007cites this paper
• Synthesis and biological activity of mustard derivatives of combretastatins.

  2005cites this paper
• Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.

  2005cites this paper
• Gene therapy of mesothelioma

  2005cites this paper
• Transduction of Soluble Flt-1 Gene to Peritoneal Mesothelial Cells Can Effectively Suppress Peritoneal Metastasis of Gastric Cancer

  2004cites this paper
• Anti-tumor gene therapy

  2004cites this paper
• Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns.

  2004cites this paper
• Biological Treatments for Lung Cancer

  2004cites this paper
• Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.

  2004cites this paper
• Pleural space as a site of ectopic gene delivery: transfection of pleural mesothelial cells with systemic distribution of gene product.

  2003cites this paper
• Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma

  2003cites this paper
• IN VIVO GENE THERAPY: A STRATEGY TO USE HUMAN GENES AS THERAPEUTICS

  2003cites this paper
• Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing

  2003cites this paper
• New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

  2002cites this paper
• Gene therapy for thoracic disease: practice, promise, and pragmatism.

  2002cites this paper
• Gentherapie bei thorakalen Malignomen

  2002cites this paper
• An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell.

  2002cites this paper
• Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells.

  2002cites this paper
• Malignant mesothelioma: options for management.

  2002cites this paper
• CHAPTER 32 – Treatment of Mesothelioma Using Adenoviral-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Gene in Combination with Ganciclovir

  2002cites this paper
• Gene therapy for lung neoplasms.

  2002cites this paper
• Gene Therapy for Malignant Mesothelioma

  2002cites this paper
• Gene therapy for lung neoplasms.

  2002cites this paper
• Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?

  2001cites this paper
• Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

  2001cites this paper
• Treatment of Mesotheliomatous Pleural Effusion: Experimental Therapy versus Thoracoscopic Talc Poudrage? Pro: Experimental Therapy

  2001cites this paper
• Adenovirus cancer gene therapy

  2001cites this paper
• Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.

  2001cites this paper
• Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis

  2000cites this paper
• Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

  2000cites this paper
• Adenovirus-mediated gene transfer into an experimental pancreatic tumour.

  2000cites this paper
• Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus

  2000cites this paper
• In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.

  1999cites this paper
• Advances in the treatment of malignant pleural mesothelioma.

  1999cites this paper
• Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells

  1999cites this paper
• Bystander effect of purine nucleoside analogues in HSV-1tk suicide gene therapy is superior to that of pyrimidine nucleoside analogues

  1999cites this paper
• Inhibition of interleukin-8 reduces human malignant pleural mesothelioma propagation in nude mouse model.

  1999cites this paper
• The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer

  1999cites this paper
• The Potential of Gene Therapy in the Peritoneal Cavity

  1999cites this paper
• Evaluation of an E1E4-Deleted Adenovirus Expressing the Herpes Simplex Thymidine Kinase Suicide Gene in Cancer Gene Therapy

  1999cites this paper
• Malignant pleural mesothelioma.

  1999cites this paper
• Use of protamine to augment adenovirus-mediated cancer gene therapy

  1999cites this paper
• Malignant pleural mesothelioma: a problematic review.

  1998cites this paper
• Gene therapy for malignant pleural mesothelioma.

  1998cites this paper
• Gene therapy for ovarian carcinoma.

  1998cites this paper
• Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma.

  1998influential citation
• Gene therapy for malignant pleural mesothelioma.

  1998cites this paper
• Clinical Approaches to Cancer Gene Therapy

  1998cites this paper
• Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis

  1998cites this paper
• Malignant pleural mesothelioma.

  1998cites this paper
• Gene therapy for lung cancer.

  1998cites this paper
• Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression

  1998cites this paper
• Genetic Modification of the Peritoneal Membrane: Potential for Improving Peritoneal Dialysis Through Gene Therapy

  1998cites this paper